Rationale for Developing New Drugs

11/7/00


Click here to start


Table of Contents

Rationale for Developing New Drugs

Toxicity in IRS-III

Clinical Drug Development

Separate Pediatric Clinical Trials

Pediatric vs. Adult MTD (1970s)

Pediatric vs. Adult MTD (1990s)

Clinical Anticancer Drug Development

Docetaxel Phase I Trials

Determinants of Chemotherapy

Molecularly-Targeted Drugs

Author: Frank M. Balis, M.D.